Healthpeak Properties, Inc. $DOC Holdings Raised by ProShare Advisors LLC

Posted by George Bondi on May 24th, 2026

ProShare Advisors LLC grew its position in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 13.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 244,533 shares of the real estate investment trust’s stock after acquiring an additional 28,211 shares during the quarter. ProShare Advisors LLC’s holdings in Healthpeak Properties were worth $3,932,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Fiduciary Trust Co boosted its position in Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock valued at $264,000 after purchasing an additional 644 shares during the period. Patton Fund Management Inc. boosted its position in Healthpeak Properties by 5.2% during the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock valued at $209,000 after purchasing an additional 648 shares during the period. Arjuna Capital boosted its position in Healthpeak Properties by 4.8% during the 3rd quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust’s stock valued at $283,000 after purchasing an additional 679 shares during the period. Quadrant Capital Group LLC boosted its position in Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after purchasing an additional 718 shares during the period. Finally, UMB Bank n.a. boosted its position in Healthpeak Properties by 23.2% during the 3rd quarter. UMB Bank n.a. now owns 4,597 shares of the real estate investment trust’s stock valued at $88,000 after purchasing an additional 867 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on DOC. Evercore lowered Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective for the company. in a research report on Monday, May 11th. UBS Group boosted their price objective on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, May 13th. Royal Bank Of Canada boosted their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Finally, Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Five analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $19.08.

Get Our Latest Analysis on Healthpeak Properties

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Stock Up 0.5%

NYSE:DOC opened at $19.74 on Friday. The firm has a market capitalization of $13.61 billion, a price-to-earnings ratio of 61.68, a PEG ratio of 2.51 and a beta of 1.00. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $19.91. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The business’s fifty day moving average price is $17.49 and its 200 day moving average price is $17.26.

Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be given a $0.1017 dividend. This represents a c) annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.